CMC-544 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)

Clinical trial NCT01134575 · COMPLETED

Trial details

NCT number: NCT01134575
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia

Start date: 2010-06-04
Primary completion: 2018-04-18
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.